American Portfolios Advisors Gilead Sciences, Inc. Transaction History

American Portfolios Advisors

  • $2.36 Trillion
  • Q3 2022

A detailed history of American Portfolios Advisors transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 22,488 shares of GILD stock, worth $2.11 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
22,488
Holding current value
$2.11 Million
% of portfolio
0.06%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023
BUY
$59.54 - $68.01 $1.34 Million - $1.53 Million
22,488 New
22,488 $1.39 Billion
Q2 2022

Mar 20, 2023
SELL
$57.72 - $65.01 $874,342 - $984,771
-15,148 Reduced 67.36%
7,340 $454 Million
Q1 2022

Mar 21, 2023
SELL
$57.92 - $72.58 $778,213 - $975,184
-13,436 Reduced 59.75%
9,052 $538 Million
Q4 2021

Mar 21, 2023
SELL
$64.88 - $73.64 $846,683 - $961,002
-13,050 Reduced 58.03%
9,438 $685 Million
Q3 2021

Mar 22, 2023
SELL
$67.69 - $73.03 $921,463 - $994,157
-13,613 Reduced 60.53%
8,875 $620 Million
Q2 2021

Mar 22, 2023
SELL
$63.47 - $69.35 $845,293 - $923,603
-13,318 Reduced 59.22%
9,170 $631 Million
Q1 2021

Mar 22, 2023
SELL
$60.0 - $68.46 $719,640 - $821,109
-11,994 Reduced 53.34%
10,494 $678 Million
Q4 2020

Mar 22, 2023
SELL
$56.65 - $64.55 $743,078 - $846,702
-13,117 Reduced 58.33%
9,371 $546 Million
Q3 2020

Mar 22, 2023
SELL
$62.1 - $78.08 $624,601 - $785,328
-10,058 Reduced 44.73%
12,430 $785 Million
Q2 2020

Mar 24, 2023
SELL
$72.34 - $84.0 $405,104 - $470,400
-5,600 Reduced 19.59%
22,979 $1.77 Billion
Q1 2020

Mar 24, 2023
BUY
$62.63 - $80.22 $381,479 - $488,620
6,091 Added 27.09%
28,579 $2.14 Billion
Q4 2019

Mar 24, 2023
SELL
$61.62 - $67.78 $536,833 - $590,499
-8,712 Reduced 38.74%
13,776 $895 Million
Q3 2019

Mar 24, 2023
SELL
$62.51 - $69.0 $37,568 - $41,469
-601 Reduced 3.82%
15,123 $958 Million
Q2 2019

Mar 24, 2023
SELL
$61.87 - $69.38 $418,488 - $469,286
-6,764 Reduced 30.08%
15,724 $1.06 Billion
Q1 2019

Mar 24, 2023
BUY
$62.53 - $70.05 $52,337 - $58,631
837 Added 6.37%
13,978 $909 Million
Q4 2018

Mar 24, 2023
SELL
$60.54 - $79.0 $188,945 - $246,559
-3,121 Reduced 19.19%
13,141 $822 Million
Q3 2018

Mar 24, 2023
SELL
$71.28 - $78.92 $443,789 - $491,355
-6,226 Reduced 27.69%
16,262 $1.26 Billion
Q2 2018

Mar 24, 2023
BUY
$64.88 - $75.68 $54,369 - $63,419
838 Added 5.26%
16,776 $1.19 Billion
Q1 2018

Mar 24, 2023
SELL
$72.84 - $88.8 $477,102 - $581,640
-6,550 Reduced 29.13%
15,938 $1.2 Billion
Q4 2017

Mar 24, 2023
SELL
$71.15 - $83.52 $535,261 - $628,320
-7,523
14,965 $1.07 Billion

Others Institutions Holding GILD

# of Institutions
1,926
Shares Held
992M
Call Options Held
10.5M
Put Options Held
9.75M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $118B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email